National Institutes of Health: Polycystic Ovary Syndrome trials

The registry lists 13 Polycystic Ovary Syndrome studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 1Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Genetics of Polycystic Ovarian SyndromeRecruitingNCT00166569
• Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) ProbandsCompletedNCT00364949Results posted
• The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsCompletedNCT03049462Phase 1
• Adrenal Hyperplasia Among Young People With PCOSCompletedNCT01313455
• Research Study for Children With a Mother or Sister With Polycystic Ovary SyndromeCompletedNCT00559390
• Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary SyndromeCompletedNCT00455338Not applicable
• PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2CompletedNCT00444288
• Environmental Factors in the Development of Polycystic Ovary SyndromeCompletedNCT00341731
• Treatment of Infertility in Women With Polycystic Ovary SyndromeCompletedNCT00068861Phase 3
• Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary SyndromeCompletedNCT00005654Not applicable
• Risk of Coronary Heart Disease in Women With Polycystic Ovary SyndromeCompletedNCT00005459
• Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary SyndromeCompletedNCT00005104Not applicable
• Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans SyndromeCompletedNCT00004311Phase 2